Bayer Showcases Innovative Portfolio at Its Fifth Consecutive China International Import Expo, Marking 140 Years in China-VCBeat

Today, Bayer, with its three divisions of Prescription Medicines (and Radiology), Consumer Health, and Crop Science, is participating in the China International Import Expo (hereinafter referred to as CIIE) for the fifth consecutive year.“CIIE”）。

Bayer's Booth at the Medical Device and Healthcare Exhibition Area

As a leader in the life sciences field, at this year's CIIE, Bayer“In China140Years, Radiating Infinite Vitality”For the theme exhibition. Adhering to“Share Health, Eliminate Hunger”With its corporate vision, Bayer has once again expanded its exhibition scale at the Medical Devices and Healthcare Products Exhibition Area compared to last year.50%, while actively leveraging its strengths in healthcare and agricultural technology to deliver a series of innovative achievements, booth activities, and interactive experiences. Meanwhile, Bayer Crop Science is also taking the lead in exhibiting at the crop seed industry zone, showcasing its extensive germplasm resources and R&D capabilities to the public, and expanding value-added opportunities for high-quality innovative development in China’s seed industry.

Bayer's booth in the crop seed industry section

“This year marks Bayer's fifth participation in the CIIE, and we also welcome our presence in China.140A milestone of the year. Along the way, Bayer has witnessed and participated in China's development and progress, which makes us deeply proud. At Bayer, we are committed to creating a better life for people and promoting health and nutrition. These are not only the most fundamental needs of humanity but also the areas where Bayer excels and focuses.”Werner, Chairman of the Board of Management of Bayer AG·Baumann (Werner Baumann）Indicates:“Since we first participated in the CIIE five years ago, we have actively collaborated with our Chinese partners to showcase our latest research achievements on the CIIE platform. As China's most important import expo, the CIIE has greatly facilitated multinational companies like Bayer to share in the opportunities presented by China and integrate into the development of China’s economy. We wish...2022"The CIIE has achieved a complete success this year, and I hope everyone can have an excellent experience at the Bayer booth."

“First Exhibition”“Debut”Gathering, Leading the Innovation Era of Life Sciences

The CIIE is a window for China to further its high-level opening up, demonstrating China's initiative to open its market to the world and share opportunities.“Opportunities in China”determination. This high-level open platform has become a gathering place for new product launches and a premier venue for showcasing new technologies. Seizing the opportunities presented by the CIIE, Bayer's four major business sectors fully demonstrated their innovative technical capabilities at the fifth CIIE, bringing more to Chinese audiences.“First Launch”、“Exhibits Turn into Goods”The achievements, sharing the ever-growing warmth of the CIIE“Spillover Effect”。

In the prescription drug field, Bayer introduces Verquvo, a chronic heart failure treatment with a novel mechanism of action.®And the first approved for use with2Non-steroidal selective mineralocorticoid receptor antagonist for type 2 diabetes-related chronic kidney disease, Kerendia®，These two products were exhibited as future innovations at the third and fourth CIIEs, garnering widespread attention due to their novel mechanism of action. They received approval in China earlier this year and are now officially being showcased as commercial products. The global synchronized submission and simultaneous approval perfectly exemplify the CIIE.“Exhibits Turn into Products”Of“Showcase Effect”、“Spillover Effect”. In addition, Vitekai®(Larotrectinib) as the first specially designedTRKHeavyweight treatments designed for adult and pediatric patients with fusion tumors also made an appearance.VitaeCare®Targeting the drivers of tumor spread and growth, rather than the primary site of the tumor, represents a significant advancement in the field of cancer treatment. VITRAKVI®The approval in China, forTRKThe integration of cancer patients provides a new treatment option, leading the way for precision oncology into a new era.

In the field of imaging diagnostics, Bayer presents two innovative and intelligent imaging diagnostic products and solutions showcased for the first time in China, demonstrating Bayer's capability to provide clear answers to support precision treatment. These include: a brand-new medical imaging artificial intelligence integration platform.Calantic®At the CIIE“China's First Exhibition”`, the platform is able to provide customers with one-stop comprehensive solutions;`MEDRAD® CentargoHigh-pressure injection system, it is Bayer's globally high work efficiencyCTThe flagship product of the high-pressure injection system, featuring three piston-based injection channels and offering information and intelligent modules.

Bayer's Consumer Health Division Unveils Elevit at CIIE®Infant Line——Little Elevit®, Two New Products of Little Elevit®VitaminDSoft Capsules and Little Elevit®Calcium Zinc VitaminDSoft capsules make their global debut at the CIIE booth, safeguarding the bone health of Chinese babies and protecting early life.1000Day; With Little Elevit®Two other Redoxon products that originated from the CIIE and are in cooperation with Xianle Health®“Calcium”New Product Recitation——Redoxon®Adult Triangle Calcium and Children Sandwich Calcium Also——Debut, Launching a New Era of Bone Health“Calcium”Nian.

Crop Science Division brings many“China International Import Expo (CIIE) Debut”, including industry-innovative plant protection solutions, UAV application mini-programs and efficacy demonstrations, digital agronomy platforms and phenology chart digital tools, digital breeding tools, and Bayer Vegetable Seeds (Seminis).“Home Gardening”Vegetable Seeds Yellow and White Bicolor Sweet Corn Saintly Affi, Six Great Dekalb®New corn varieties (joint ventures), seed coatings, disruptive short-stalk corn and smart corn systems, climate-smart business models, etc., lead agricultural modernization and jointly build resilience in the food system.

Riding the Wave of High-Quality Development“Blue Ocean”, Expanding in China“Moments”

As the dual circulation connecting China and the world“Collection Point”, the CIIE is Bayer's embrace of China's development opportunities and expansion in China“Moments”The door of opportunity has indeed deepened Bayer's interactions with governments at all levels, industry partners, and consumers. By“Win-Win Cooperation”As the main theme, Bayer is actively exploring diversified local cooperation models in research and development and business models, committed to bringing more products and solutions that meet local needs to Chinese patients, consumers, and growers more quickly. Leveraging the fifth China International Import Expo (CIIE), Bayer plans to carry out a series of significant collaborations with a wide range of partners in the coming days, injecting vitality into a new round of high-quality development for itself in the healthcare and agricultural technology fields.

In the healthcare sector, Bayer is actively responding and supporting“Healthy China”Strategy, strengthen local innovation cooperation, and make relentless efforts to achieve innovative results beneficial to patients and consumers in China. During the CIIE, Bayer HealthCare will join hands with a team of experts from Peking University School of Public Health to launch under the China Association for Science and Technology.“SciTech China”Projects; and reached cooperation agreements on resource integration and advantage sharing with local innovative enterprises such as Xinhua Pharmaceutical and Clara, in an effort to meet the growing health needs of Chinese consumers; in addition, Bayer will also cooperate with media, government, associations, experts, chain pharmacies, and upstream and downstream enterprises to carry out multi-form science popularization work at the booth, promoting patients' and consumers' awareness of health management.

In the field of agricultural technology, Bayer collaborates with industry chain partners covering the entire life cycle of crop growth to contribute to the advancement of China's agricultural and rural modernization. During the CIIE, Bayer Crop Science will sign an investment agreement with the Qiantang District of Hangzhou to further meet the demands of the Chinese and Asia-Pacific markets; Bayer“Yunyuan Farm”Will Welcome Two New Partners——Reached a cooperation intention signing with Shanghai Pudong New Area, and signed an agreement with Shandong Pingyuan Luwang Group.——To apply globally leading sustainable agriculture concepts to the cultivation and production of field crops in China; Bayer also plans to collaborate with local companies such as Yara, iKON Agriculture, Benlai Life, Green Leaf Investment, and Two Rivers Convergence for agreements, providing end-to-end digital agriculture solutions to help digitization take wing in China's agricultural industry chain.

A Century of Heritage Meets Modern Innovation, Rooted in China with an Unwavering Original Aspiration

Rooted in China for 140 years, Bayer, with its commitment to leadership in the life sciences, has always shared a common destiny with China. It continuously contributes to the realization of the "Healthy China" and "Rural Revitalization" goals within the "2035 Vision." Along the way, Bayer has used vitality as its brush and ink, painting a vibrant and hopeful picture of the times with bold strokes.

To Commemorate and Celebrate Bayer in China140In a historic moment spanning years, Bayer joins hands with Zhou Liwei, a national intangible cultural heritage artist and the fourth-generation inheritor of Weixian paper-cutting, to present the magnificent beauty of this century-old paper-cutting art in China.140The Year in Life Sciences: Tradition and Innovation. During the CIIE, the two parties jointly released and exhibited this papercut art piece, blending art and technology, combining ancient and modern elements, to usher in a new chapter symbolizing Bayer's boundless vitality for its next century in China.

Bayer has signed up in advance to participate in the 6th CIIE. As a global leader in the life sciences industry, Bayer will leverage its global innovation network and continue to utilize the CIIE as a platform that brings together resources from all over the world.“China Stage”, accelerate the pace of local innovation, and continuously bring more cutting-edge innovative products and solutions to China, creating a better life for Chinese patients, consumers, and growers.

Today, Bayer, with its three divisions of prescription drugs (and imaging diagnostics), consumer health products, and crop science, is participating in the China International Import Expo (hereinafter referred to as CIIE) for the fifth consecutive year.“CIIE”）。

Bayer's booth in the medical device and healthcare exhibition area

As a leader in the life sciences field, at this year's CIIE, Bayer“In China140Years, radiating infinite vitality”To participate in the exhibition with a theme. Adhering to“Share Health, Eliminate Hunger”With its corporate vision, Bayer has further expanded its exhibition scale at the Medical Devices and Healthcare Products Exhibition compared to last year.50%, while focusing on leveraging its strengths in healthcare and agricultural technology to deliver a series of innovative achievements, booth activities, and interactive experiences. Meanwhile, Bayer Crop Science is also taking the lead in exhibiting at the crop seed industry zone, showcasing its extensive germplasm resources and R&D capabilities to the public, and expanding value-added opportunities for high-quality innovative development in China’s seed industry.

“This year marks Bayer's fifth participation in the CIIE, and we also welcome our presence in China.140A milestone of the year. Along the way, Bayer has witnessed and participated in China's development and progress, for which we are deeply proud. At Bayer, we are committed to creating a better life for people, promoting health and nutrition. These are not only the most fundamental needs of humanity but also the areas where Bayer excels and focuses.”Werner, Chairman of the Board of Management of Bayer AG·Baumann (Werner Baumann）Indicates:“Since participating in the CIIE for the first time five years ago, we have actively collaborated with our Chinese partners to showcase our latest research achievements on the CIIE platform. As China's most important import expo, the CIIE has greatly facilitated multinational companies like Bayer to share in the opportunities of China and integrate into the development landscape of China’s economy. Best wishes.2022"The CIIE has achieved a complete success this year, and I hope everyone can have an excellent experience at the Bayer booth."

“First Exhibition”“Debut”Converge, Lead the Era of Life Science Innovation

The CIIE is a window for China to further its high-level opening-up, demonstrating China's initiative to open its market to the world and share opportunities.“Opportunities in China”determination. This high-level open platform has become a gathering place for new product launches and a premier venue for showcasing new technologies. Seizing the opportunities presented by the CIIE, Bayer's four business sectors fully demonstrated their innovative technological capabilities at the fifth CIIE, bringing more to Chinese audiences.“First Launch”、“Exhibits Turn into Products”The achievements, sharing the ever-increasing warmth of the CIIE“Spillover Effect”。

In the prescription drug field, Bayer introduces Verquvo, a chronic heart failure treatment with a novel mechanism of action.®And the first approved for use with2Non-steroidal selective mineralocorticoid receptor antagonist for type 2 diabetes-related chronic kidney disease: Kerendia®，These two products were exhibited as future innovations at the third and fourth CIIE, gaining widespread attention for their novel mechanisms of action. They received approval in China in the first half of this year and are now officially being exhibited as commercial products. The global synchronized submission and simultaneous approval perfectly reflect the essence of the CIIE.“Exhibits Turn into Goods”Of“Showcase Effect”、“Spillover Effect”. In addition, Vitekai®(Larotrectinib) as the first drug specifically designed forTRKHeavyweight Treatment Drugs Designed for Adult and Pediatric Patients with Fusion Tumors Also Make an Appearance.VitaeCare®Targeting the drivers of tumor spread and growth, rather than the primary site of the tumor, represents a significant advancement in the field of cancer treatment. VITRAKVI®The approval in China, forTRKThe integration of cancer patients provides a new treatment option, leading the way for precision oncology into a new era.

In terms of imaging diagnostics, Bayer has brought two innovative and intelligent imaging diagnostic products and solutions for their first exhibition in China, showcasing Bayer's capability to provide clear answers to support precision treatment. Including: a brand-new medical imaging artificial intelligence integration platform.Calantic®At the CIIE“China's First Exhibition”, the platform is able to provide customers with one-stop comprehensive solutions;MEDRAD® CentargoHigh-pressure injection system, it is Bayer's globally high work efficiencyCTThe flagship product of the high-pressure injection system, featuring three piston-based injection channels and offering information and intelligent modules.

Bayer's Consumer Health Division Unveils Elevit at the CIIE®Infant Line——Little Elevit®, Two New Products of Little Elevit®VitaminDSoft Capsules and Little Elevit®Calcium Zinc VitaminDSoft capsules make their global debut at the CIIE booth, safeguarding the bone health of Chinese babies and protecting early life.1000Day; With Little Elevit®Two other Redoxon products with the same origin at the CIIE, in collaboration with Xianle Health.®“Calcium”New Product Recitation——Effort Stretch®Adult Triangle Calcium and Children Sandwich Calcium Also——Debut, Launching a New Era of Bone Health“Calcium”Nian.

Crop Science Division brings many“First Exhibition at CIIE”, including industry-innovative plant protection solutions, UAV application mini-programs and efficacy demonstrations, digital agronomy platforms and phenology chart digital tools, digital breeding tools, and Bayer's vegetable brand Seminis.“Home Gardening”Vegetable Seeds Yellow-White Bicolor Sweet Corn Saintly Aifei, Six Major Dekalb®New corn varieties (joint ventures), seed coating agents, disruptive dwarf corn and smart corn systems, climate-smart business models, etc., lead agricultural modernization and build resilience in the food system.

Riding the Wave of High-Quality Development“Blue Ocean”, Expanding in China“Moments”

As the dual circulation connecting China and the world“Collection Point”, the CIIE is Bayer's embrace of development opportunities in China and expansion in China“Moments”The door of opportunity has indeed deepened Bayer's interactions with governments at all levels, industry partners, and consumers. Through“Win-Win Cooperation”As the main theme, Bayer is actively exploring diversified local cooperation models in research and development and business models, committed to bringing more products and solutions that meet local needs to Chinese patients, consumers, and growers more quickly. Leveraging the fifth China International Import Expo (CIIE), Bayer plans to carry out a series of significant collaborations with its broad network of partners in the coming days, injecting vitality into a new round of high-quality development for itself in the healthcare and agricultural technology fields.

In the healthcare sector, Bayer is actively responding and supporting“Healthy China”Strategy, strengthen local innovation cooperation, and make relentless efforts to achieve innovative results beneficial to patients and consumers in China. During the CIIE, Bayer HealthCare will join hands with a team of experts from Peking University School of Public Health to launch under the China Association for Science and Technology.“SciTech China”Projects; and reached cooperation agreements on resource integration and advantage sharing with local innovative enterprises such as Xinhua Pharmaceutical and Clauli, striving to meet the growing health needs of Chinese consumers; in addition, Bayer will also collaborate with media, government, associations, experts, chain pharmacies, and upstream and downstream enterprises to carry out various forms of science popularization activities at the booth, promoting patients' and consumers' awareness of health management.

In the field of agricultural technology, Bayer collaborates with industry chain partners covering the entire life cycle of crop growth to contribute to the advancement of China's agricultural and rural modernization. During the CIIE, Bayer Crop Science will sign an investment agreement with the Qiantang District of Hangzhou to further meet the demands of the Chinese and Asia-Pacific markets; Bayer“Yunyuan Farm”Will Welcome Two New Partners——Reached a cooperation intention signing with Shanghai Pudong New Area, and signed an agreement with Shandong Pingyuan Luwang Group.——To apply globally leading sustainable agriculture concepts to the cultivation and production of field crops in China; it is also planned to collaborate with local companies such as Yara, iKON Agriculture, Benlai Life, GreenLeaf Investment, and Two Rivers Convergence for agreements, providing end-to-end digital agriculture solutions to help digitization take wing in China’s agricultural industry chain.

A Century of Heritage Meets Modern Innovation, Rooted in China with an Unwavering Original Aspiration

To Commemorate and Celebrate Bayer in China140In a historic moment, Bayer, together with Zhou Liwei, a national intangible cultural heritage artist and the fourth-generation inheritor of Weixian paper-cutting, presents the beauty of this century-old paper-cutting art that has been passed down for over a hundred years in China.140The Year in Life Sciences: Tradition and Innovation. During the CIIE, both parties jointly released and exhibited this paper-cut art piece, blending art and technology, using a method that harmonizes the ancient with the modern, opening a new chapter symbolizing Bayer's boundless vitality in China for the next hundred years.

Bayer has signed up in advance to participate in the 6th CIIE. As a global leader in the life sciences industry, Bayer will continue to leverage the CIIE, a platform that brings together resources from all over the world, relying on its global innovation network.“China Stage”, accelerate the pace of local innovation, and continuously bring more cutting-edge innovative products and solutions to China, creating a better life for Chinese patients, consumers, and growers.